Deema Munif Alotaibi

Deema Munif Alotaibi

orcid

Research Focus & Metrics

Representative Publications

View All Publications
17 November 2026 in Healthcare
Verified
Journal Article
Open access
PDF file
AAAlanoud Alomair
Alanoud Alomair
AAAlanood Abdulrhman Almusaiteer
Alanood Abdulrhman Almusaiteer
RAReem Mohammed Ababtain
Reem Mohammed Ababtain
SASara Essa Alotaibi
Sara Essa Alotaibi
RARana Hrimal Alotibi
Rana Hrimal Alotibi
DADeema Munif Alotaibi
Deema Munif Alotaibi
Background: Biologic therapies have improved outcomes in patients with severe uncontrolled chronic rhinosinusitis with nasal polyps (CRSwNP), but reliable biomarkers predicting treatment response remain unclear. This systematic review and meta-analysis evaluated predictive biomarkers associated with response to biologic therapy. Methods: A systematic review of randomized controlled trials and observational studies evaluating biomarkers of response to biologic therapy in severe uncontrolled CRSwNP was conducted. Data were extracted using a standardized form, and quantitative synthesis was performed where appropriate. Risk of bias was assessed using the Cochrane risk-of-bias 2 tool and the Newcastle–Ottawa Scale. Results: The most frequently investigated predictors of treatment response included blood eosinophil count, serum IgE, tissue eosinophilia, FeNO, and clinical characteristics such as comorbid asthma and NSAID-exacerbated respiratory disease (NSAID-ERD). Biologic therapy consistently improved clinical outcomes; however, evidence supporting any single biomarker as a reliable predictor of treatment response remained inconsistent because of substantial heterogeneity across studies. Conclusions: Current evidence does not support a universally validated predictive biomarker for biologic response in severe uncontrolled CRSwNP. Further standardized, prospective studies are needed to enable personalized biologic therapy.

1 January 2026 in Obstetrics and Gynecology International
Verified
Journal Article
Open access
PDF file
Elhadi MiskeenElhadi Miskeen
Elhadi Miskeen
AAAtheer Hameed Alqarni
Atheer Hameed Alqarni
DADalia Alqarni
Dalia Alqarni
AAAbdullah Ayed
Abdullah Ayed
RAReema Dakhilallah Alghanmi
Reema Dakhilallah Alghanmi
OSOmar Safar
Omar Safar
Background: Urinary incontinence (UI) is a prevalent yet underreported condition significantly impacting women’s quality of life. In Saudi Arabia, cultural stigma often prevents help‐seeking, and comprehensive data on its impact are limited. This study aimed to estimate the prevalence and severity of UI among women in Saudi Arabia, identify associated medical and obstetric risk factors, and evaluate its impact on quality of life in order to inform a policy and service framework for integrated, stigma‐sensitive care. Methods: A cross‐sectional study was conducted among 629 adult women across Saudi Arabia using an online, self‐administered questionnaire. The instrument included sociodemographic sections, the validated International Consultation on Incontinence Questionnaire‐Short Form (ICIQ‐UI SF), and assessments of risk factors and quality‐of‐life impact. Data were analyzed using descriptive statistics, chi‐square tests, and multiple logistic regression. Results: Regarding the amount leaked among the 291 women who reported incontinence, most reported small‐volume leakage: 238 (81.8%), while moderate 51 (17.5%) and large amounts 2 (0.7%) were relatively rare. Key risk factors identified included higher age, overweight/obesity (with 60.7% of frequent UI cases being overweight), and multiparity (46.3% of all women had ≥ 3 deliveries). The impact on quality of life was substantial: 25.4% reported an impact on their social life, and 21.0% reported feelings of anxiety or nervousness. Multivariable analysis revealed that severe social impact was independently associated with high leakage frequency (AOR = 4.25, p < 0.001), higher perceived interference (AOR = 1.28, p < 0.001), and experiencing anxiety (AOR = 3.02, p = 0.005). Conclusion: UI is highly prevalent among women in Saudi Arabia, with significant physical and psychosocial consequences. Symptom severity and psychological distress are the primary drivers of social impairment. There is an urgent need for targeted public health initiatives to destigmatize UI, raise awareness, and improve access to treatment. These findings support a national framework that embeds routine UI screening in primary care, strengthens access to pelvic‐floor and weight‐management services, and integrates mental‐health support and culturally sensitive awareness campaigns to reduce stigma and improve quality of life.